Are you Dr. Weinstein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 13 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1656 N California Blvd
Suite 200
Walnut Creek, CA 94596Phone+1 925-952-2888Fax+1 925-952-2845- Is this information wrong?
Summary
- Dr. Richard Weinstein, MD is an endocrinologist in Walnut Creek, California. He is currently licensed to practice medicine in California.
Education & Training
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1964 - 1966- Mount Sinai Medical Center of ClevelandInternship, Transitional Year, 1963 - 1964
University of Virginia School of MedicineClass of 1963
Certifications & Licensure
CA State Medical License 1971 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- The Effect of Betahistine on Body Weight in Obese Subjects Start of enrollment: 2007 Jan 01
- Study of DA-9801 to Treat Diabetic Neuropathy Start of enrollment: 2013 Nov 01
- A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial.McClung, M. R.,Lewiecki, E. M.,Geller, M. L.,Bolognese, M. A.,Peacock, M.,Weinstein, R. L.,Ding, B.,Rockabrand, E.,Wagman, R. B.,Miller, P. D.> ;Osteoporos Int. 2013 Jan
- 21 citationsImpact of Mifepristone, a Glucocorticoid/Progesterone Antagonist, on HDL Cholesterol, HDL Particle Concentration, and HDL FunctionStephanie T. Page, Ronald M. Krauss, Coleman Gross, Brian Y. Ishida, Jay W. Heinecke, Chongren Tang, John K. Amory, Peter M. Schaefer, Cheryl J. Cox, John P. Kane, Jon...> ;The Journal of Clinical Endocrinology and Metabolism. 2012 Mar 7
- 96 citationsEffect of denosumab on bone mineral density and biochemical markers of bone turnover: six-year results of a phase 2 clinical trial.Paul D. Miller, Rachel B. Wagman, Munro Peacock, E. Michael Lewiecki, Michael A. Bolognese, Richard L. Weinstein, Beiying Ding, Javier San Martin, Michael R. McClung> ;The Journal of Clinical Endocrinology and Metabolism. 2011 Feb 1
- Join now to see all
